Company / Cash per Share
Forte Biosciences, Inc. Cash per Share History
FY2018-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.77
FY2019
5-year range
$0.28 / $1.77
FY2018-FY2019
Trend
+540.3%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
1.77 in FY2019.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, cash per share increased 540.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $1.77 | +540.3% |
| FY2018 | $0.28 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026